PNC Financial Services Group’s Zenas BioPharma ZBIO Stock Holding History

PNC Financial Services Group’s Portfolio ZBIO Stock Details ZBIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$120K	Sell	4,739 -28	-0.6%	-$557	﹤0.01%	2801
2026 Q1	$93.2K	Sell	4,767 -1,057	-18%	-$23.7K	﹤0.01%	2861
2025 Q4	$211K	Sell	5,824 -19	-0.3%	-$625	﹤0.01%	2271
2025 Q3	$130K	Sell	5,843 -3,336	-36%	-$54.3K	﹤0.01%	2619
2025 Q2	$88.9K	Buy	9,179 +2,679	+41%	+$26.1K	﹤0.01%	2789
2025 Q1	$51.4K	Buy	6,500 +83	+1%	+$649	﹤0.01%	3075
2024 Q4	$52.6K	Buy	6,417 +2,568	+67%	+$40.1K	﹤0.01%	3076
2024 Q3	$65.1K	Buy	+3,849	New	+$69.2K	﹤0.01%	2934

Other funds holding ZBIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

SOCM

SR One Capital Management Wayne, Pennsylvania $1.04B AUM 262.99% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

PCH

Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

RPSM

Royalty Pharma Sub-Manager New York $242M AUM

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.51B AUM 546.08% 1-Year Est. Return

PNC Financial Services Group's ZBIO Position: Q2 2026 in Review

PNC Financial Services Group reduced its Zenas BioPharma (ZBIO) stake by 0.59% in Q2 2026, selling an estimated $557 and leaving 4,739 shares worth $120K. The position accounts for ﹤0.01% of the portfolio, ranked #2801.

PNC Financial Services Group first reported a position in ZBIO in Q3 2024 and has held it in 8 quarters since. The position peaked at $211K in Q4 2025. 144 funds tracked by Wall St. Rank hold ZBIO as of Q2 2026.

PNC Financial Services Group held 4,739 shares of Zenas BioPharma worth $120K as of Q2 2026.
PNC Financial Services Group sold 28 Zenas BioPharma shares in Q2 2026, an estimated $557.
Zenas BioPharma made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #2801 holding.
PNC Financial Services Group first reported a position in Zenas BioPharma in Q3 2024 and has held it in 8 quarters since.
PNC Financial Services Group's Zenas BioPharma position peaked at $211K in Q4 2025.
144 funds tracked by Wall St. Rank held Zenas BioPharma as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.